References
- 1. RAVINDRANATH Y. Evolution of modern treatment of childhood acute leukemia and cancer: adventures and battles in the 1970s and 1980s. Pediatr Clin North Am. 2015; 62(1):1-10.
- 2. BLEEKER FE., HOPMAN SM., MERKS JH., AALFS CM., HENNEKAM RC. Brain tumors and syndromes in children. Neuropediatrics. 2014; 45(3):137-61.
- 3. MILLARD NE., DUNKEL IJ. Advances in the management of central nervous system germ cell tumors. Curr Oncol Rep. 2014; 16(7):393.
- 4. THORP NJ., TAYLOR RE. Management of central nervous system tumours in children. Clin Oncol (R Coll Radiol). 2014; 26(7):438-45.
- 5. CHEUK DK., LEE TL., CHIANG AK., HA SY., CHAN GC. Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children. J Neurooncol. 2008; 86(3):337-47.
- 6. SANDU N., SCHALLER B. Stem cell transplantation in brain tumors: a new field for molecular imaging? Mol Med. 2010; 16(9-10):433-7.
- 7. COHEN AL., COLMAN H. Glioma biology and molecular markers. Cancer Treat Res. 2015; 163:15-30.
- 8. WURDINGER T., DEUMELANDT K., VAN DER VLIET HJ., WESSELING P., DE GRUIJL TD. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Biochim Biophys Acta. 2014; 1846(2):560-75.
- 9. NAKANO I. Stem cell signature in glioblastoma: therapeutic development for a moving target. J Neurosurg. 2015; 122(2):324-30.
- 10. CHINTAGUMPALA M., GAJJAR A. Brain tumors. PediatrClin North Am. 2015;62(1):167-78.
- 11. THOMAS C., BHATIA S. Cancer: brain-regulated biphasic stress response induces cell growth or cell death to adapt to psychological stressors. Adv Mind Body Med. 2014; 28(3):14-21.
- 12. AMBADY P., BETTEGOWDA C., HOLDHOFF M. Emerging methods for disease monitoring in malignant gliomas. CNS Oncol. 2013; 2(6):511-22.
- 13. CARMIGNANI M., VOLPE AR., ALDEA M., SORITAU O., IRIMIE A., FLORIAN IS., et al. Glioblastoma stem cells: a new target for metformin and arsenic trioxide. J Biol Regul Homeost Agents. 2014; 28(1):1-15.
- 14. ALDEA M., CRACIUN L., TOMULEASA C., BERINDAN-NEAGOE I., KACSO G., FLORIAN IS., et al. Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery. Tumour Biol. 2014; 35(6):5101-10.
- 15. ALDEA M., TOMULEASA C., PETRUSHEV B., SUSMAN S., KACSO GI., IRIMIE A., et al. Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology? J BUON. 2011; 16(3):409-13.
- 16. FLORIAN IS., TOMULEASA C., SORITAU O., TIMIS T., IOANI H., IRIMIE A., et al. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy. J BUON. 2011; 16(1):16-23.
- 17. AIKEN R. Molecular neuro-oncology and the challenge of the blood-brain barrier. Semin Oncol. 2014; 41(4):438-45.
- 18. SINGHAL T., ALAVI A., KIM CK. Brain: positron emission tomography tracers beyond 18F fluorodeoxyglucose. PET Clin. 2014; 9(3):267-76.
- 19. JUHÁSZ C., DWIVEDI S., KAMSON DO., MICHELHAUGH SK., MITTAL S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging. 2014; 13.
- 20. WHITFIELD GA., KENNEDY SR., DJOUKHADAR IK., JACKSON A. Imaging and target volume delineation in glioma. Clin Oncol (R Coll Radiol). 2014; 26(7):364-76.
- 21. HARTMANN O., VALTEAU-COUANET D., VASSAL G., LAPIERRE V., BRUGIERES L., DELGADO R, et al. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution. Bone Marrow Transplant. 1999; 23(8):789-95.
- 22. DUPUIS-GIROD S., HARTMANN O., BENHAMOU E., DOZ F., MECHINAUD F., BOUFFET E., et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol. 1996; 27(1):87-98.
- 23. VALTEAU-COUANET D., FILLIPINI B., BENHAMOU E., GRILL J., KALIFA C., COUANET D., et al. High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. Bone Marrow Transplant. 2005; 36(11):939-45.
- 24. SECONDINO S., PEDRAZZOLI P., SCHIAVETTO I., Basilico V., BRAMERIO E., MASSIMINO M, et al. Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma. Bone Marrow Transplant. 2008; 42(2):131-3.
- 25. NISHIKAWA T., OKAMOTO Y., TANABE T., SHINKODA Y., KODAMA Y., HIGASHI M., et al. Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation. Bone Marrow Transplant. 2010; 45(3):602-4.
- 26. LAFAY-COUSIN L., HADER W., WEI XC., NORDAL R., STROTHER D., HAWKINS C., et al. Post-chemotherapy maturation in supratentorial primitive neuroectodermal tumors. Brain Pathol. 2014; 24(2):166-72.
- 27. CLEMENT J., VARLOTTO J., RYBKA W., FRAUENHOFFER E., DRABICK JJ. Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation. J Clin Oncol. 2013; 31(19):e316-9.
- 28. VELJKOVIC D., VUJIC D., NONKOVIC OS., JEVTIC D., ZECEVIC Z, LAZIC E. Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors. Ther Apher Dial. 2011; 15(6):579-86.
- 29. NEGRETTI L., BLANCHARD P., COUANET D., KIEFFER V., GOMA G., HABRAND JL., et al. Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival. Neuro Oncol. 2012; 14(11):1413-21.
- 30. SANGER F., NICKLEN S., COULSON AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977; 74(12):5463-7.
- 31. QUAIL MA., SMITH M., COUPLAND P., OTTO TD., HARRIS SR., CONNOR TR., et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012; 13:341.
- 32. METZKER ML. Sequencing technologies – the next generation. Nat Rev Genet. 2010; 11(1):31-46.
- 33. GRADA A., WEINBRECHT K. Next-generation sequencing: methodology and application. J Invest Dermatol. 2013; 133 (8):e11.
- 34. MELDRUM C, DOYLE MA, TOTHILL RW. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev. 2011; 32(4):177-95.
- 35. ROBINSON J., HALLIWELL JA., MCWILLIAM H., LOPEZ R., PARHAM P., MARSH SG. The IMGT/HLA database. Nucleic Acids Res. 2013; 41(Database issue):D1222-7.
- 36. JUNG HL. Shedding a new light on the HLA matching. Korean J Hematol. 2011; 46(1):1-2.
- 37. GABRIEL C., DANZEL M., HACKL C., KOPAL G., HUFNAGL P., HOFER K., et al. Rapid high-throughput human leucocyte antigen typing by massive parallel pyrosequencing for high-resolution allele identification. Hum. Immunol. 2009, 70, 960-64.
- 38. BENTLEY G., HIGUCHI R., HOGLUND B., GOODRIDGE D., SAYER D., TRACHTENBERG EA, et al. High-resolution, high-throughput HLA genotyping by next generation sequencing. Tissue Antigens 2009, 74, 393-403.
- 39. HOLCOMB CL., HÖGLUND B., ANDERSON MW., BLAKE LA., BÖHME I., EGHOLM M., et al. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens. 2011; 77(3):206-17.
- 40. WANG C., KRISHNAKUMAR S., WILHELMY J., BABRZADEH F., STEPANYAN L., SU LF., et al. High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci USA. 2012; 109(22):8676-81.
- 41. DANZER M., NIKLAS N., STABENTHEINER S., HOFER K., PRÖLL J., STÜCKLER C., et al. Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnostics. BMC Genomics. 2013; 14:221.
- 42. MOONSAMY PV., WILLIAMS T., BONELLA P., HOLCOMB CL., HOGLUND BN., HILLMAN G., et al. High Throughput HLA genotyping using 454 sequencing and the FluidigmAccess ArrayTM system for simplified amplicon library preparation. Tissue Antigens 2013, 81, 141-49.
- 43. CHANG CJ., CHEN PL., YANG WS., CHAO KM. A fault-tolerant method for HLA typing with PacBio data. BMC Bioinformatics. 2014; 15:296.
- 44. EHRENBERG PK., GERETZ A., BALDWIN KM., APPS R., POLONIS VR., ROBB ML., et al. High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging. BMC Genomics. 2014; 15:864.
- 45. SMITH AG., PYO CW., NELSON W., GOW E., WANG R., SHEN S., et al. Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors. Hum Immunol. 2014; 75(10):1040-6.
- 46. ZHOU M., GAO D., CHAI X., LIU J., LAN Z., LIU Q., et al. Application of high-throughput, high-resolution and cost-effective next generation sequencing-based large-scale HLA typing in donor registry. Tissue Antigens. 2015; 85(1):20-8.